Nov 8 (Reuters) - North China Pharmaceutical Co LTd
600812.SS :
* SAYS UNIT'S ANTI-MONOPOLY CASE HAS BEEN RECINDED BY U.S. COURT IN NEW YORK
Source text Further company coverage: 600812.SS
(Reporting by Hong Kong newsroom)
((meg.shen@thomsonreuters.com; 852-39525805;))